D. Medical Advances Most in a Month After Receiving U.S. Patent

D. Medical Industries Ltd. rose the most in a month after the maker of drug-delivery devices received a U.S. patent for technology that combines a continuous glucose monitor and insulin pump in the same product.

The shares jumped 5.8 percent, the most since Oct. 27, to 6.949 shekels at 11:10 a.m. in Tel Aviv, giving the Ramat Gan, Israel-based company a market value of 54.9 million shekels ($14.5 million).

To contact the reporter on this story: Susan Lerner in Jerusalem at slerner2@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.